Stock Yards Bank & Trust Co. Has $9.20 Million Holdings in Humana Inc. (NYSE:HUM)

Stock Yards Bank & Trust Co. increased its holdings in Humana Inc. (NYSE:HUM - Free Report) by 12.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 20,103 shares of the insurance provider's stock after buying an additional 2,285 shares during the quarter. Stock Yards Bank & Trust Co.'s holdings in Humana were worth $9,203,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Dorsey & Whitney Trust CO LLC boosted its holdings in shares of Humana by 2.6% in the third quarter. Dorsey & Whitney Trust CO LLC now owns 817 shares of the insurance provider's stock worth $397,000 after buying an additional 21 shares during the last quarter. UMB Bank n.a. raised its stake in Humana by 2.8% during the 3rd quarter. UMB Bank n.a. now owns 805 shares of the insurance provider's stock worth $392,000 after acquiring an additional 22 shares during the period. First Financial Corp IN raised its stake in Humana by 7.2% during the 4th quarter. First Financial Corp IN now owns 343 shares of the insurance provider's stock worth $157,000 after acquiring an additional 23 shares during the period. PDS Planning Inc raised its stake in Humana by 4.1% during the 3rd quarter. PDS Planning Inc now owns 609 shares of the insurance provider's stock worth $296,000 after acquiring an additional 24 shares during the period. Finally, First Trust Direct Indexing L.P. raised its stake in Humana by 0.8% during the 3rd quarter. First Trust Direct Indexing L.P. now owns 2,926 shares of the insurance provider's stock worth $1,424,000 after acquiring an additional 24 shares during the period. Hedge funds and other institutional investors own 92.38% of the company's stock.

Insider Transactions at Humana

In other news, Director Jorge S. Mesquita bought 545 shares of the firm's stock in a transaction dated Tuesday, February 20th. The stock was bought at an average price of $367.09 per share, for a total transaction of $200,064.05. Following the transaction, the director now owns 2,578 shares in the company, valued at $946,358.02. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 0.29% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts have commented on HUM shares. Wells Fargo & Company decreased their target price on shares of Humana from $413.00 to $350.00 and set an "overweight" rating on the stock in a research note on Monday, April 8th. The Goldman Sachs Group lowered their price objective on shares of Humana from $450.00 to $385.00 and set a "buy" rating for the company in a research note on Wednesday, April 3rd. Oppenheimer reiterated an "outperform" rating and issued a $630.00 target price on shares of Humana in a report on Wednesday, January 17th. Cantor Fitzgerald reissued a "neutral" rating and set a $391.00 price target on shares of Humana in a research report on Wednesday, April 10th. Finally, StockNews.com lowered shares of Humana from a "strong-buy" rating to a "hold" rating in a report on Friday, January 26th. Eleven equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $454.63.

Humana Stock Down 0.9 %

HUM stock traded down $3.03 during midday trading on Monday, hitting $325.30. 1,581,877 shares of the company's stock were exchanged, compared to its average volume of 1,992,417. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.63. Humana Inc. has a 12-month low of $299.23 and a 12-month high of $541.21. The firm has a 50 day moving average price of $330.40 and a 200-day moving average price of $400.22. The stock has a market capitalization of $39.25 billion, a price-to-earnings ratio of 16.61, a price-to-earnings-growth ratio of 1.92 and a beta of 0.45.

Humana (NYSE:HUM - Get Free Report) last issued its earnings results on Thursday, January 25th. The insurance provider reported ($0.11) EPS for the quarter, missing the consensus estimate of $0.76 by ($0.87). The firm had revenue of $26.46 billion during the quarter, compared to analyst estimates of $25.47 billion. Humana had a return on equity of 19.44% and a net margin of 2.34%. Humana's revenue was up 17.9% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.62 EPS. On average, analysts anticipate that Humana Inc. will post 16.06 EPS for the current year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be given a $0.885 dividend. The ex-dividend date is Friday, June 28th. This represents a $3.54 annualized dividend and a dividend yield of 1.09%. Humana's payout ratio is 17.86%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.